Cargando…
A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival
The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of dialysis. Peritoneal dialysis (PD) is an established treatment for ESRD patients worldwide; it has a variety of advantages, including autonomy and flexibility, as well as economic benefits in many co...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Nephrology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331972/ https://www.ncbi.nlm.nih.gov/pubmed/28428932 http://dx.doi.org/10.23876/j.krcp.2017.36.1.22 |
_version_ | 1782511463307411456 |
---|---|
author | Kim, Hyunwook Ryu, Dong-Ryeol |
author_facet | Kim, Hyunwook Ryu, Dong-Ryeol |
author_sort | Kim, Hyunwook |
collection | PubMed |
description | The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of dialysis. Peritoneal dialysis (PD) is an established treatment for ESRD patients worldwide; it has a variety of advantages, including autonomy and flexibility, as well as economic benefits in many countries compared to hemodialysis (HD). However, the long-term survival rate of PD remains poor. Although direct comparison of survival rate between the dialysis modalities by randomized controlled trials is difficult due to the ethical issues, it has always been a crucial point when deciding which dialysis modality should be recommended to patients. Recently, in many countries, including the United States, Brazil, Spain, Australia, and New Zealand, the survival rate in PD patients has significantly improved. PD patient survival in Korea has also improved, but Korean PD patients are known to have higher risk of mortality and major adverse cardiovascular, cerebrovascular events than HD patients. Herein, we further evaluate why Korean PD patients had worse outcomes; we suggest that special attention should be paid to patients with diabetes, coronary artery disease, or congestive heart failure when they choose PD as the first dialysis modality in order to reduce mortality risk. |
format | Online Article Text |
id | pubmed-5331972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Korean Society of Nephrology |
record_format | MEDLINE/PubMed |
spelling | pubmed-53319722017-04-20 A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival Kim, Hyunwook Ryu, Dong-Ryeol Kidney Res Clin Pract Review Article The number of patients with end-stage renal disease (ESRD) has rapidly increased, as has the cost of dialysis. Peritoneal dialysis (PD) is an established treatment for ESRD patients worldwide; it has a variety of advantages, including autonomy and flexibility, as well as economic benefits in many countries compared to hemodialysis (HD). However, the long-term survival rate of PD remains poor. Although direct comparison of survival rate between the dialysis modalities by randomized controlled trials is difficult due to the ethical issues, it has always been a crucial point when deciding which dialysis modality should be recommended to patients. Recently, in many countries, including the United States, Brazil, Spain, Australia, and New Zealand, the survival rate in PD patients has significantly improved. PD patient survival in Korea has also improved, but Korean PD patients are known to have higher risk of mortality and major adverse cardiovascular, cerebrovascular events than HD patients. Herein, we further evaluate why Korean PD patients had worse outcomes; we suggest that special attention should be paid to patients with diabetes, coronary artery disease, or congestive heart failure when they choose PD as the first dialysis modality in order to reduce mortality risk. Korean Society of Nephrology 2017-03 2017-03-31 /pmc/articles/PMC5331972/ /pubmed/28428932 http://dx.doi.org/10.23876/j.krcp.2017.36.1.22 Text en Copyright © 2017 by The Korean Society of Nephrology This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Kim, Hyunwook Ryu, Dong-Ryeol A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title | A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title_full | A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title_fullStr | A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title_full_unstemmed | A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title_short | A prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
title_sort | prime determinant in selecting dialysis modality: peritoneal dialysis patient survival |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5331972/ https://www.ncbi.nlm.nih.gov/pubmed/28428932 http://dx.doi.org/10.23876/j.krcp.2017.36.1.22 |
work_keys_str_mv | AT kimhyunwook aprimedeterminantinselectingdialysismodalityperitonealdialysispatientsurvival AT ryudongryeol aprimedeterminantinselectingdialysismodalityperitonealdialysispatientsurvival AT kimhyunwook primedeterminantinselectingdialysismodalityperitonealdialysispatientsurvival AT ryudongryeol primedeterminantinselectingdialysismodalityperitonealdialysispatientsurvival |